NeurATRIS NeurATRIS
  • English version
  • Version Française

  • Home

    Home

  • NeurATRIS

    NeurATRIS

    • Who are we ?

      Who are we ?

    • Objectives: Research and Services

      Objectives: Research and Services

    • Management

      Management

    • NeurATRIS Network

      NeurATRIS Network

      • Institutional network

        Institutional network

      • Scientific and medical network

        Scientific and medical network

  • Research Programs

    Research Programs

    • Cellular therapies

      Cellular therapies

    • Gene therapies

      Gene therapies

    • In vivo evaluation and therapeutic efficacy

      In vivo evaluation and therapeutic efficacy

    • Drug therapies

      Drug therapies

  • The NeurATRIS Offer

    The NeurATRIS Offer

    • NeurARIS' actions

      NeurARIS' actions

      • Training support

        Training support

      • Research support

        Research support

      • Scientific events

        Scientific events

    • Our tools

      Our tools

      • ALZHEIMER

        ALZHEIMER

      • PARKINSON

        PARKINSON

      • HUNTINGTON

        HUNTINGTON

      • MULTIPLE SCLEROSIS

        MULTIPLE SCLEROSIS

      • NEURODEVELOPMENTAL DISORDERS

        NEURODEVELOPMENTAL DISORDERS

    • NeurAtris platforms

      NeurAtris platforms

      • NeurAtris platforms

        NeurAtris platforms

      • CEA Paris- Saclay / MIRCen platforms

        CEA Paris- Saclay / MIRCen platforms

      • ICM platforms - GHU Pitié Salpêtrière

        ICM platforms - GHU Pitié Salpêtrière

      • Henri Mondor Hospital platforms

        Henri Mondor Hospital platforms

      • N-BIPS Bicêtre Hospital Platforms

        N-BIPS Bicêtre Hospital Platforms

      • Oniris Nantes / INRAE platforms

        Oniris Nantes / INRAE platforms

      • Robert-Debré Hospital/NeuroDiderot platforms

        Robert-Debré Hospital/NeuroDiderot platforms

      • I-Stem Platforms

        I-Stem Platforms

    • A continuum in translational research

      A continuum in translational research

    • How to collaborate

      How to collaborate

    • Submit a project

      Submit a project

  • EATRIS

    EATRIS

  • Search

    Search

  • Home
  • NeurATRIS
    • Who are we ?
    • Objectives: Research and Services
    • Management
    • NeurATRIS Network
      • Institutional network
      • Scientific and medical network
  • Research Programs
    • Cellular therapies
    • Gene therapies
    • In vivo evaluation and therapeutic efficacy
    • Drug therapies
  • The NeurATRIS Offer
    • NeurARIS' actions
      • Training support
      • Research support
      • Scientific events
    • Our tools
      • ALZHEIMER
      • PARKINSON
      • HUNTINGTON
      • MULTIPLE SCLEROSIS
      • NEURODEVELOPMENTAL DISORDERS
    • NeurAtris platforms
      • NeurAtris platforms
      • CEA Paris- Saclay / MIRCen platforms
      • ICM platforms - GHU Pitié Salpêtrière
      • Henri Mondor Hospital platforms
      • N-BIPS Bicêtre Hospital Platforms
      • Oniris Nantes / INRAE platforms
      • Robert-Debré Hospital/NeuroDiderot platforms
      • I-Stem Platforms
    • A continuum in translational research
    • How to collaborate
    • Submit a project
  • EATRIS
  • Search
  • News
  • Schedule
  • Contact
  1. Home >
  2. News >
  3. NeurATRIS supports the Gordon Conference on "Neuroimmune Communication in Health and Disease"

NeurATRIS supports the Gordon Conference on "Neuroimmune Communication in Health and Disease"

 

The Gordon conference "Neuroimmune Communication in Health and Disease", will take place from January 22 to 27, 2023, at the Ventura Beach Marriott Ventura, California.

The 5-day conference will cover topics including developmental neuroimmunology, glial cells, the gut-brain axis, brain barriers, neurodegeneration, tissue inflammation and infectious diseases.

More details.

Created: 21 November 2022

Contacts
Legals

This website is using Cookies. By navigating, you accept this use.